What Factors Impact upon a Woman's Decision to Undertake Genetic Cancer Testing?
- PMID: 24432248
- PMCID: PMC3880931
- DOI: 10.3389/fonc.2013.00325
What Factors Impact upon a Woman's Decision to Undertake Genetic Cancer Testing?
Abstract
Introduction: The advent of human genome project has lead to genetic tests that identify high-risk states for certain cancers. Many are privately marketed on the Internet. Despite the availability of tests, limited data has evaluated factors that lead to test uptake. The aim of the present study was to explore the attitudes of a cohort of new mothers toward uptake of a genetic cancer test with a 50% predictive value of cancer.
Methods: A cross-sectional survey was undertaken. The project targeted women who had recently given birth at an Australian tertiary referral hospital. Women were asked about a theoretical blood test that detected an increased risk for the development of cancer. Attitudes and knowledge questionnaires were completed.
Results: Of 232 consecutive women approached, 32 declined, giving a response rate of 86.2%. Only 63 (31.5%) women stated they would have the test. Absence of religious belief, higher level of education, better knowledge of terms used in genetics, an absence of concern over emotional, employment, and insurance discrimination, and previous acceptance of Down syndrome screening in pregnancy were each associated with significantly higher rate of test uptake in univariate analysis (all p < 0.03). In multivariate analysis, a lack of concern over discrimination and a history of having accepted Down syndrome screening in the previous pregnancy remained significantly associated with test uptake (all p < 0.0001).
Conclusion: Concern over discrimination and having made a prior decision to have genetic testing were the principal factors associated with decision-making.
Keywords: breast cancer; discrimination; education; ethics; genetic cancer screening; pregnancy.
Similar articles
-
Women's Attitudes Toward Invasive and Noninvasive Testing When Facing a High Risk of Fetal Down Syndrome.JAMA Netw Open. 2019 Mar 1;2(3):e191062. doi: 10.1001/jamanetworkopen.2019.1062. JAMA Netw Open. 2019. PMID: 30924894 Free PMC article.
-
Attitudes of women of childbearing age towards prenatal diagnosis in southeastern France.Prenat Diagn. 1993 Jul;13(7):613-27. doi: 10.1002/pd.1970130712. Prenat Diagn. 1993. PMID: 8415427
-
Factors affecting mothers' knowledge of genetic screening.Aust N Z J Obstet Gynaecol. 2004 Feb;44(1):30-4. doi: 10.1111/j.1479-828X.2004.00171.x. Aust N Z J Obstet Gynaecol. 2004. PMID: 15089865
-
Prenatal screening for fetal aneuploidy in singleton pregnancies.J Obstet Gynaecol Can. 2011 Jul;33(7):736-750. doi: 10.1016/S1701-2163(16)34961-1. J Obstet Gynaecol Can. 2011. PMID: 21749752
-
Intention to pursue genetic testing for breast cancer among women due for screening mammography.Cancer Epidemiol Biomarkers Prev. 2003 Feb;12(2):96-102. Cancer Epidemiol Biomarkers Prev. 2003. PMID: 12582018 Review.
Cited by
-
Psychosocial, attitudinal, and demographic correlates of cancer-related germline genetic testing in the 2017 Health Information National Trends Survey.J Community Genet. 2019 Oct;10(4):453-459. doi: 10.1007/s12687-018-00405-4. Epub 2019 Feb 20. J Community Genet. 2019. PMID: 30835082 Free PMC article.
-
Effects of personal cancer history and genomic risk information on mothers' psychological adaptation to inherited breast/ovarian cancer syndrome.Psychol Health Med. 2025 Feb;30(2):297-308. doi: 10.1080/13548506.2024.2417311. Epub 2024 Oct 21. Psychol Health Med. 2025. PMID: 39433288
-
Massively Parallel Sequencing for Rare Genetic Disorders: Potential and Pitfalls.Front Endocrinol (Lausanne). 2021 Feb 19;11:628946. doi: 10.3389/fendo.2020.628946. eCollection 2020. Front Endocrinol (Lausanne). 2021. PMID: 33679611 Free PMC article. Review.
-
Breast Cancer Genetics Knowledge and Testing Intentions among Nigerian Professional Women.J Genet Couns. 2018 Aug;27(4):863-873. doi: 10.1007/s10897-017-0194-4. Epub 2017 Dec 19. J Genet Couns. 2018. PMID: 29260484
-
Stakeholder Perspectives on Overcoming Barriers to Cascade Testing in Lynch Syndrome: A Qualitative Study.Cancer Prev Res (Phila). 2020 Dec;13(12):1037-1046. doi: 10.1158/1940-6207.CAPR-20-0141. Epub 2020 Jul 29. Cancer Prev Res (Phila). 2020. PMID: 32727822 Free PMC article.
References
-
- Codori AM, Petersen GM, Miglioretti DL, Larkin EK, Bushey MT, Young C, et al. Attitudes toward colon cancer gene testing: factors predicting test uptake. Cancer Epidemiol Biomarkers Prev (1999) 8:345–51 - PubMed
-
- Friedman LC, Webb JA, Bruce S, Weinberg AD, Cooper HP. Skin cancer prevention and early detection intentions and behavior. Am J Prev Med (1995) 11:59–65 - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources